These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 20133020)

  • 1. [Experience with 123I-Iodobenzamide in the differential diagnosis of Parkinson's disease and Parkinson-plus disease].
    Paniagua Correa C; García Alonso P; Balsa Bretón MA; Mariana Monguía A; Penín González FJ; Pey Illera C
    Rev Esp Med Nucl; 2010; 29(2):57-62. PubMed ID: 20133020
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Loss of dopamine-D2 receptor binding sites in Parkinsonian plus syndromes.
    Hierholzer J; Cordes M; Venz S; Schelosky L; Harisch C; Richter W; Keske U; Hosten N; Mäurer J; Poewe W; Felix R
    J Nucl Med; 1998 Jun; 39(6):954-60. PubMed ID: 9627325
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Quantitative analysis of striatal dopamine D2 receptors with 123 I-iodolisuride SPECT in degenerative extrapyramidal diseases.
    Prunier C; Tranquart F; Cottier JP; Giraudeau B; Chalon S; Guilloteau D; De Toffol B; Chossat F; Autret A; Besnard JC; Baulieu JL
    Nucl Med Commun; 2001 Nov; 22(11):1207-14. PubMed ID: 11606886
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [SPECT with 123I-IBZM: utility in differential diagnosis of degenerative Parkinsonisms and establishment of quantification method].
    Poblete García V; García Vicente A; Ruíz Solís S; Martínez Delgado C; Vaamonde J; Rodado Marina S; Cortés Romera M; Talavera Rubio M; Ibáñez R; Soriano Castrejón A
    Rev Esp Med Nucl; 2005; 24(4):234-43. PubMed ID: 16122407
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Dopamine (D2) receptor SPECT with 123I-iodobenzamide (IBZM) in diagnosis of Parkinson syndrome].
    Reiche W; Grundmann M; Huber G
    Radiologe; 1995 Nov; 35(11):838-43. PubMed ID: 8657887
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Initial experiences with 123-Iodine-IBZM neuroreceptor scintigraphy in extrapyramidal disorders].
    Pávics L; Dibó G; Ambrus E; Séra T; Vécsei L; Csernay L
    Orv Hetil; 2000 May; 141(20):1073-7. PubMed ID: 10851890
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [The differential diagnosis of Parkinson diseases--123I-IBZM-SPECT vs. the apomorphine test].
    Hierholzer J; Cordes M; Schelosky L; Sander B; Böck JC; David I; Horowski R; Poewe W
    Rofo; 1993 Jul; 159(1):86-90. PubMed ID: 8334264
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cortical and subcortical patterns of I-123 iodobenzamide SPECT in striatal D(2) receptor parkinsonisms.
    Pifarré P; Cuberas G; Hernández J; Lorenzo C; Miquel F; Castell-Conesa J
    Clin Nucl Med; 2010 Apr; 35(4):228-33. PubMed ID: 20305408
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Correlation of clinical response in apomorphine test with D2-receptor status as demonstrated by 123I IBZM-SPECT.
    Schelosky L; Hierholzer J; Wissel J; Cordes M; Poewe W
    Mov Disord; 1993 Oct; 8(4):453-8. PubMed ID: 8232354
    [TBL] [Abstract][Full Text] [Related]  

  • 10. 123I-iodobenzamide-SPECT in 83 patients with de novo parkinsonism.
    Schwarz J; Tatsch K; Arnold G; Ott M; Trenkwalder C; Kirsch CM; Oertel WH
    Neurology; 1993 Dec; 43(12 Suppl 6):S17-20. PubMed ID: 8264906
    [TBL] [Abstract][Full Text] [Related]  

  • 11. 123I-IBZM SPECT: reconstruction methodology and results in parkinsonism and dystonia.
    Berding G; Gratz KF; Kolbe H; Meyer GJ; Dengler R; Knoop BO; Hundeshagen H
    Nuklearmedizin; 1994 Oct; 33(5):194-9. PubMed ID: 7997377
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Cerebral SPECT with iodine-123 IBZM in patients with extrapyramidal system disorders: the evaluation of its sensitivity in therapy with dopaminergic drugs].
    Hierholzer J; Castelli L; Cordes M; Schelosky L; Poewe W; Felix R
    Radiol Med; 1996 Mar; 91(3):207-10. PubMed ID: 8628932
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of diffusion-weighted imaging and [123I]IBZM-SPECT for the differentiation of patients with the Parkinson variant of multiple system atrophy from those with Parkinson's disease.
    Seppi K; Schocke MF; Donnemiller E; Esterhammer R; Kremser C; Scherfler C; Diem A; Jaschke W; Wenning GK; Poewe W
    Mov Disord; 2004 Dec; 19(12):1438-45. PubMed ID: 15390073
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Iodine-123-epidepride-SPECT: studies in Parkinson's disease, multiple system atrophy and Huntington's disease.
    Pirker W; Asenbaum S; Wenger S; Kornhuber J; Angelberger P; Deecke L; Podreka I; Brücke T
    J Nucl Med; 1997 Nov; 38(11):1711-7. PubMed ID: 9374338
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Significance of non-presynaptic SPECT tracer methods in Parkinson's disease.
    Leenders KL
    Mov Disord; 2003 Oct; 18 Suppl 7():S39-42. PubMed ID: 14531045
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [The determination of cerebral dopamine (D2) receptor density by using 123I-IBZM-SPECT in Parkinson disease patients].
    Hierholzer J; Cordes M; Schelosky L; Barzen G; Poewe W; Henkes H; Keske U; Horowski R; Felix R
    Rofo; 1992 Oct; 157(4):390-8. PubMed ID: 1391843
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Role of dopamine transporter imaging in investigation of parkinsonian syndromes in routine clinical practice.
    Poewe W; Scherfler C
    Mov Disord; 2003 Oct; 18 Suppl 7():S16-21. PubMed ID: 14531041
    [TBL] [Abstract][Full Text] [Related]  

  • 18. 123I-beta-CIT and 123I-IBZM-SPECT scanning in levodopa-naive Parkinson's disease.
    Wenning GK; Donnemiller E; Granata R; Riccabona G; Poewe W
    Mov Disord; 1998 May; 13(3):438-45. PubMed ID: 9613734
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Continuous intravenous infusion of iodine-123-IBZM for SPECT determination of human brain dopamine receptor occupancy by antipsychotic agent RWJ-37796.
    Seibyl JP; Zea-Ponce Y; Brenner L; Baldwin RM; Krystal JH; Offord SJ; Mochoviak S; Charney DS; Hoffer PB; Innis RB
    J Nucl Med; 1996 Jan; 37(1):11-5. PubMed ID: 8543979
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Diagnostic value of 123I-ioflupane and 123I-iodobenzamide SPECT scans in 248 patients with parkinsonian syndromes.
    Vlaar AM; de Nijs T; Kessels AG; Vreeling FW; Winogrodzka A; Mess WH; Tromp SC; van Kroonenburgh MJ; Weber WE
    Eur Neurol; 2008; 59(5):258-66. PubMed ID: 18264015
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.